- Home
- SBFG vs GALT Comparison
SBFG vs GALT Comparison
Compare SBFG & GALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBFG
- GALT
- Stock Information
- Founded
- SBFG 1983
- GALT 2000
- Country
- SBFG United States
- GALT United States
- Employees
- SBFG 251
- GALT N/A
- Industry
- SBFG Major Banks
- GALT Biotechnology: Pharmaceutical Preparations
- Sector
- SBFG Finance
- GALT Health Care
- Exchange
- SBFG Nasdaq
- GALT Nasdaq
- Market Cap
- SBFG 139.1M
- GALT 147.8M
- IPO Year
- SBFG N/A
- GALT N/A
- Fundamental
- Price
- SBFG $20.91
- GALT $1.04
- Analyst Decision
- SBFG
- GALT Strong Buy
- Analyst Count
- SBFG 0
- GALT 1
- Target Price
- SBFG N/A
- GALT $11.00
- AVG Volume (30 Days)
- SBFG 37.7K
- GALT 1.1M
- Earning Date
- SBFG 01-23-2025
- GALT 11-13-2024
- Dividend Yield
- SBFG 2.77%
- GALT N/A
- EPS Growth
- SBFG 3.68
- GALT N/A
- EPS
- SBFG 1.74
- GALT N/A
- Revenue
- SBFG $56,732,000.00
- GALT N/A
- Revenue This Year
- SBFG N/A
- GALT N/A
- Revenue Next Year
- SBFG $4.16
- GALT N/A
- P/E Ratio
- SBFG $11.99
- GALT N/A
- Revenue Growth
- SBFG 1.21
- GALT N/A
- 52 Week Low
- SBFG $13.01
- GALT $0.73
- 52 Week High
- SBFG $23.00
- GALT $4.27
- Technical
- Relative Strength Index (RSI)
- SBFG 45.57
- GALT 20.80
- Support Level
- SBFG $20.98
- GALT $1.80
- Resistance Level
- SBFG $23.00
- GALT $2.36
- Average True Range (ATR)
- SBFG 0.65
- GALT 0.27
- MACD
- SBFG -0.08
- GALT -0.08
- Stochastic Oscillator
- SBFG 0.00
- GALT 15.07
About SBFG SB Financial Group Inc.
SB Financial Group Inc operates as a Holding Company of State Bank and RDSI/DCM. Its activities involve commercial banking, trust, and financial services. It offers a full-range of financial services for consumers and small businesses, including trust services, mortgage banking, wealth management services, commercial and agricultural lending. It accepts deposits, such as checking accounts, savings accounts, money market accounts, demand deposits, and time certificates of deposit. It earns revenue in the form of interest income.
About GALT Galectin Therapeutics Inc.
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.